跳至主要内容
临床试验/IRCT20190312043037N1
IRCT20190312043037N1已完成3 期

se of azelastine and sodium chloride for prevention of sinusitis in ICU admitted patients

Artesh University of Medical Sciences0 个研究点目标入组 126 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients aged more than 18 years during the first 24 hours after Nasogasteric tube insertion were randomized into either the treatment or control group.

排除标准

  • Trauma to the head and face or anatomical abnormalities preventing Nasogasteric tube placement.
  • History of sinusitis in the last three months.
  • Leukopenia (white blood cell<3500 / ml)
  • Coagulation disorders (platelet<100000 / ml, International Normalized Ratio (INR)> 1.5 or Prothrombin time test (PTT) more than two times higher than normal)
  • Presence of a tumor in the patient's head and neck

研究者

发起方
Artesh University of Medical Sciences

相似试验